CareDx, Inc (CDNA) financial statements and ratios from SEC XBRL: revenue $0.5B (TTM), net margin -5.6%, revenue growth 13.8% YoY, P/E 22.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $379.81M |
| Revenue (TTM) | $0.5B |
| Net Margin | -5.6% |
| Operating Margin (TTM) | 25.0% |
| Revenue Growth (YoY) | 13.8% |
| EPS Growth (YoY) | -140.0% |
| P/E Ratio | 22.3 |
| EV / EBITDA | 16.0 |
| Price / Book | 6.18 |
| Price / Sales | 5.62 |
| FCF Yield | 1.2% |
| Altman Z-Score | 12.85 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
CDNA overview · CDNA earnings · CDNA KPIs · CDNA documents · CDNA ownership · CDNA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.